Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Association of circulating VacA-neutralizing antibodies with gastric cancer and duodenal ulcer.

Ayala G, Flores-Luna L, Hernández-Amaro D, Mendoza-Hernández G, Chihu-Amparán L, Bernal-Sahagún F, Camorlinga M, Lazcano-Ponce E, Torres J.

Cancer Causes Control. 2011 Oct;22(10):1425-34. doi: 10.1007/s10552-011-9817-5. Epub 2011 Jul 21.

PMID:
21779758
2.

Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.

Sezikli M, Guliter S, Apan TZ, Aksoy A, Keles H, Ozkurt ZN.

Int J Clin Pract. 2006 Oct;60(10):1239-43. Epub 2006 Mar 27.

PMID:
16669834
4.

CagA and VacA: virulence factors of Helicobacter pylori in Thai patients with gastroduodenal diseases.

Mahachai V, Tangkijvanich P, Wannachai N, Sumpathanukul P, Kullavanijaya P.

Helicobacter. 1999 Sep;4(3):143-7.

PMID:
10469187
5.

Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.

Yamaoka Y, Kodama T, Kashima K, Graham DY.

J Clin Pathol. 1999 Mar;52(3):215-8.

6.

Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases--cross-sectional study.

Filipec Kanizaj T, Katicić M, Presecki V, Gasparov S, Colić Cvrlje V, Kolarić B, Mrzljak A.

Croat Med J. 2009 Apr;50(2):124-32.

8.

CagA and VacA Helicobacter pylori antibodies in gastric cancer.

Suriani R, Colozza M, Cardesi E, Mazzucco D, Marino M, Grosso S, Sanseverinati S, Venturini I, Borghi A, Zeneroli ML.

Can J Gastroenterol. 2008 Mar;22(3):255-8.

9.

Serological response to Helicobacter pylori recombinant antigens in Chilean infected patients with duodenal ulcer, non-ulcer dyspepsia and gastric cancer.

Opazo P, Müller I, Rollán A, Valenzuela P, Yudelevich A, García-de la Guarda R, Urra S, Venegas A.

APMIS. 1999 Dec;107(12):1069-78.

PMID:
10660136
10.

Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development.

Iaquinto G, Todisco A, Giardullo N, D'Onofrio V, Pasquale L, De Luca A, Andriulli A, Perri F, Rega C, De Chiara G, Landi M, Taccone W, Leandro G, Figura N.

Dig Liver Dis. 2000 Jun-Jul;32(5):378-83.

PMID:
11030181
11.

A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.

Song H, Michel A, Nyrén O, Ekström AM, Pawlita M, Ye W.

Int J Cancer. 2014 Jun 15;134(12):2942-50. doi: 10.1002/ijc.28621. Epub 2013 Dec 3.

12.

Helicobacter pylori vacA, iceA, and cagA status and pattern of gastritis in patients with malignant and benign gastroduodenal disease.

Miehlke S, Yu J, Schuppler M, Frings C, Kirsch C, Negraszus N, Morgner A, Stolte M, Ehninger G, Bayerdörffer E.

Am J Gastroenterol. 2001 Apr;96(4):1008-13.

PMID:
11316139
13.
14.

Anti-CagA and anti-VacA antibodies in Helicobacter pylori-infected patients with and without peptic ulcer disease in Serbia and Montenegro.

Sokic-Milutinovic A, Wex T, Todorovic V, Milosavljevic T, Malfertheiner P.

Scand J Gastroenterol. 2004 Mar;39(3):222-6.

PMID:
15074390
15.

Analysis of serum antibody profile against H pylori VacA and CagA antigens in Turkish patients with duodenal ulcer.

Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, Tuncer M, Kocazeybek B.

World J Gastroenterol. 2006 Nov 14;12(42):6869-73.

16.

CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.

Palli D, Masala G, Del Giudice G, Plebani M, Basso D, Berti D, Numans ME, Ceroti M, Peeters PH, Bueno de Mesquita HB, Buchner FL, Clavel-Chapelon F, Boutron-Ruault MC, Krogh V, Saieva C, Vineis P, Panico S, Tumino R, Nyrén O, Simán H, Berglund G, Hallmans G, Sanchez MJ, Larrãnaga N, Barricarte A, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT, Boeing H, Weikert C, Linseisen J, Nagel G, Overvad K, Thomsen RW, Tjonneland A, Olsen A, Trichoupoulou A, Trichopoulos D, Arvaniti A, Pera G, Kaaks R, Jenab M, Ferrari P, Nesi G, Carneiro F, Riboli E, Gonzalez CA.

Int J Cancer. 2007 Feb 15;120(4):859-67. Erratum in: Int J Cancer. 2007 Aug 15;121(4):928. E Numans, Mattijs [corrected to Numans, Mattijs E].

17.

Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.

Rudi J, Kolb C, Maiwald M, Zuna I, von Herbay A, Galle PR, Stremmel W.

Dig Dis Sci. 1997 Aug;42(8):1652-9.

PMID:
9286230
18.

Multiple gene status in Helicobacter pylori strains and risk of gastric cancer development.

Douraghi M, Talebkhan Y, Zeraati H, Ebrahimzadeh F, Nahvijoo A, Morakabati A, Ghafarpour M, Esmaili M, Bababeik M, Oghalaie A, Rakhshani N, Hosseini ME, Mohagheghi MA, Mohammadi M.

Digestion. 2009;80(3):200-7. doi: 10.1159/000229774. Epub 2009 Sep 15.

PMID:
19752557
19.

Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.

Adamsson J, Lundin SB, Hansson LE, Sjövall H, Svennerholm AM.

Helicobacter. 2013 Feb;18(1):73-82. doi: 10.1111/j.1523-5378.2012.00991.x. Epub 2012 Sep 21.

PMID:
23067268
20.

High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients.

Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N.

Int J Cancer. 1994 Jan 2;56(1):56-60.

PMID:
8262677
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk